Erytech Pharma S.A.: ERYTECH Announces Receipt of Nasdaq Not

ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022 - ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing

Related Keywords

France , United States , Cambridge , Cambridgeshire , United Kingdom , Paris , France General , New Jersey , Mathilde Bohin Louis Victor Delouvrier , Nicolas Merigeau , Pharma Bio , Eric Soyer , Company American Depositary Shares Adss , Company Adss , Company Securities , Nasdaq , Exchange Commission , Company Annual Report On Form , Nasdaq Stock Market , Euronext , American Depositary Shares , Nasdaq Listing Rule , Notification Letter , Nasdaq Global Select Market , Next Biotech , Private Securities Litigation Reform Act , Nasdaq Listing , French Autorit , Des March , Registration Document , Annual Report , Nasdaq Notice , Erytech , Dharma , Nnounces , Receipt , Notice ,